Attached files

file filename
8-K - FORM 8-K - ALBEMARLE CORPd245621d8k.htm

Exhibit 99.1

 

   Contact:   
LOGO    Lorin Crenshaw    225.388.7322

Albemarle Reports Third Consecutive Record Quarter

 

 

BATON ROUGE, LA - October 24, 2011 –

Third quarter 2011 highlights:

 

 

Record quarterly earnings for the third consecutive quarter of $1.28 per share, up 25 percent over third quarter 2010 results.

 

 

Net sales of $723 million for the quarter, up 24 percent from third quarter 2010.

 

 

Record quarterly net sales and income for our Catalysts segment.

 

 

EBITDA of $189 million and EBITDA margin of 26 percent for the quarter.

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 

In thousands, except per share amounts

   2011      2010      2011      2010  

Net sales

   $ 722,977       $ 585,036       $ 2,161,615       $ 1,757,789   

Segment income

   $ 186,411       $ 143,899       $ 538,191       $ 383,340   

Net income attributable to Albemarle Corporation

   $ 116,098       $ 93,689       $ 336,837       $ 238,748   

Diluted earnings per share

   $ 1.28       $ 1.02       $ 3.66       $ 2.59   

Special item per share

   $ —         $ —         $ —         $ 0.05   
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted earnings per share excluding special item

   $ 1.28       $ 1.02       $ 3.66       $ 2.64   
  

 

 

    

 

 

    

 

 

    

 

 

 

Albemarle Corporation (NYSE: ALB) reported third quarter 2011 earnings of $116.1 million, or $1.28 per share, compared to third quarter 2010 earnings of $93.7 million, or $1.02 per share. The Company reported net sales of $723.0 million in the third quarter of 2011 compared to net sales of $585.0 million in the third quarter of 2010.

Earnings for the nine months ended September 30, 2011 were $336.8 million, or $3.66 per share, compared to $238.7 million, or $2.59 per share, for the same period in 2010. Excluding the $7.0 million ($4.6 million after tax, or 5 cents per share) charge for restructuring costs in the first quarter of 2010, earnings for the nine months ended September 30, 2010 were $243.3 million, or $2.64 per share. Net sales for the nine months ended September 30, 2011 were $2.2 billion compared to $1.8 billion for the same period in 2010.

 

1


Commenting on results, Luke Kissam, President and CEO, stated, “We’re pleased to announce record earnings for the third consecutive quarter. Catalysts’ record performance and the continued strength of the Fine Chemistry business more than offset the expected volume softness seen in Polymer Solutions this quarter versus the first half of the year. These earnings are a testament to our competitive cost position, execution of our pricing strategies and the innovation of our people.”

Quarterly Segment Results

Catalysts generated net sales of $299.5 million in the third quarter of 2011, a 39 percent increase over net sales in the third quarter of 2010, due mainly to favorable pricing and volume impacts as well as favorable impacts from foreign currency. Catalysts segment income was $101.9 million in the third quarter of 2011, up 48 percent over third quarter 2010 results of $68.9 million due primarily to the favorable pricing gains noted above, partly offset mainly by higher variable input costs versus the third quarter of 2010.

Polymer Solutions delivered net sales of $243.9 million in the third quarter of 2011, a five percent increase over net sales in the third quarter of 2010, due to favorable pricing and foreign currency impacts partially offset by lower volumes. Segment income for Polymer Solutions was $54.6 million in the third quarter of 2011, a seven percent decline from $58.5 million in the third quarter of 2010, due primarily to lower volumes and higher variable input costs, partly offset by favorable pricing.

Fine Chemistry net sales in the third quarter of 2011 were $179.5 million, a 30 percent increase over net sales in the third quarter of 2010, due mainly to favorable pricing and volume impacts. Segment income for Fine Chemistry was $30.0 million for the third quarter of 2011, over 80 percent higher than third quarter 2010 results of $16.5 million. This improvement in segment income was due primarily to the favorable pricing and volume performance noted above, partly offset by higher variable input costs and higher charges attributable to noncontrolling interests.

Corporate and Other

Corporate and other expense was $23.5 million for the third quarter of 2011. The increase over the comparable period in 2010 was due mainly to higher personnel-related costs.

Interest and financing expenses increased to $9.7 million for the third quarter of 2011 compared to $6.1 million for the third quarter of 2010, primarily due to higher average interest rates on outstanding borrowings during the 2011 period.

Our third quarter 2011 effective income tax rate was 25.1 percent versus 24.1 percent in the third quarter of 2010. The full year 2011 effective tax rate is expected to be 23.7 percent. Our effective tax rate continues to be influenced by the level and geographic mix of income and benefits from a favorable mix of income in lower tax jurisdictions.

 

2


Cash Flow

Our cash flow from operations was approximately $285 million for the nine months ended September 30, 2011, and we had $481.3 million in cash and cash equivalents at September 30, 2011. During the nine months ended September 30, 2011, cash on hand and cash provided by operations funded capital expenditures for plant, machinery and equipment of $127.1 million (versus $50.0 million in the same period of 2010) and dividends to shareholders of $43.1 million. During the third quarter of 2011, we repurchased 3.0 million shares of our common stock as authorized under the terms of our stock repurchase plan. Additionally, we made repayments of long-term debt of $105.1 million and pension and postretirement contributions of $57.6 million during the nine months ended September 30, 2011.

On September 22, 2011, we amended and restated our previous $675.0 million credit facility. Under the terms of the amended and restated five-year, revolving, unsecured credit facility, we have the ability to borrow $750.0 million, which may be increased by an additional $250.0 million. Borrowings under the new credit facility bear interest at the London Inter-Bank Offered Rate plus a spread, currently 0.975%, that varies with our debt rating. We had $120.0 million in outstanding borrowings on this facility at September 30, 2011.

Outlook

We are closely monitoring customer order patterns and other performance trends in our businesses and the markets which they serve in light of current uncertainties in the global economy. While we expect the typical slower year end order patterns in some of our businesses, we believe our businesses are fundamentally strong and still expect that our second half 2011 results will be similar to the first half of the year. We expect to end 2011 well positioned for another successful year in 2012.

Earnings Call

The Company’s performance for the third quarter ended September 30, 2011 will be discussed on a conference call at 11:00 AM Eastern Daylight time on October 25, 2011. The call can be accessed by dialing 800-299-7928 (International Dial In # 617-614-3926), and entering conference ID 71549443. The Company’s earnings presentation and supporting material can be accessed through Albemarle’s website under Investors at www.albemarle.com.

About Albemarle

Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. Albemarle is committed to global sustainability and is continuing to advance its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry, with Corporate Responsibility Magazine naming Albemarle among its prestigious “100 Best Corporate Citizens” list for

 

3


2011. Albemarle employs approximately 4,000 people and serves customers in approximately 100 countries. Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings and other information regarding the Company, its businesses and markets served.

Forward-Looking Statements

Some of the information presented in this press release, including, without limitation, statements with respect to product development, improvements in productivity, market trends, price and mix changes, expected growth, outlook and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. There can be no assurance that actual results will not differ materially. Factors that could cause actual results to differ from expectations include, without limitation: changes in economic and business conditions; changes in financial and operating performance of our major customers and industries and markets served by us; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in the demand for our products; limitations or prohibitions on the manufacture and sale of our products; availability of raw materials; changes in the cost of raw materials and energy and in our ability to pass through increases; acquisitions and divestitures, and changes in performance of acquired companies; fluctuations in foreign currencies; changes in laws and government regulation of our operations or our products; the occurrence of claims or litigation; the occurrence of natural disasters; the inability to maintain current levels of product or premises liability insurance or the denial of such coverage; political unrest, including terrorism or hostilities; political instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of our earnings; changes in monetary policies or inflation or interest rates, which may impact our ability to raise capital or increase our cost of funds, the performance of our pension fund investments and our pension expense and funding obligations; volatility and substantial uncertainties in the debt and equity markets; technology or intellectual property infringement and other risks; decisions we may make in the future; and the other factors detailed from time to time in the reports we file with the SEC, including those described under “Risk Factors” in our Annual Report on Form 10-K and our 2011 Quarterly Reports on Form 10-Q.

 

4


Albemarle Corporation and Subsidiaries

Consolidated Statements of Income

(In Thousands Except Per Share Amounts) (Unaudited)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011     2010  

Net sales

   $ 722,977      $ 585,036      $ 2,161,615      $ 1,757,789   

Cost of goods sold

     464,965        388,213        1,418,638        1,208,328   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     258,012        196,823        742,977        549,461   

Selling, general and administrative expenses

     77,169        61,924        233,115        195,319   

Research and development expenses

     20,534        14,336        58,096        43,722   

Restructuring and other charges (a)

     —          —          —          6,958   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating profit

     160,309        120,563        451,766        303,462   

Interest and financing expenses

     (9,710     (6,139     (28,576     (18,059

Other income, net

     956        1,303        534        1,584   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes and equity in net income of unconsolidated investments

     151,555        115,727        423,724        286,987   

Income tax expense

     38,097        27,886        100,423        68,917   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before equity in net income of unconsolidated investments

     113,458        87,841        323,301        218,070   

Equity in net income of unconsolidated investments (net of tax)

     9,500        9,179        37,118        29,950   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     122,958        97,020        360,419        248,020   

Net income attributable to noncontrolling interests

     (6,860     (3,331     (23,582     (9,272
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to Albemarle Corporation

   $ 116,098      $ 93,689      $ 336,837      $ 238,748   
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic earnings per share

   $ 1.29      $ 1.03      $ 3.70      $ 2.61   

Diluted earnings per share

   $ 1.28      $ 1.02      $ 3.66      $ 2.59   

Weighted-average common shares outstanding – basic

     89,935        91,312        91,094        91,335   

Weighted-average common shares outstanding – diluted

     90,958        92,082        92,090        92,129   

See accompanying notes to the condensed consolidated financial information.

 

5


Albemarle Corporation and Subsidiaries

Condensed Consolidated Balance Sheets

(In Thousands) (Unaudited)

 

     September 30,
2011
     December 31,
2010
 

ASSETS

     

Cash and cash equivalents

   $ 481,258       $ 529,650   

Other current assets

     968,096         818,548   
  

 

 

    

 

 

 

Total current assets

     1,449,354         1,348,198   
  

 

 

    

 

 

 

Property, plant and equipment

     2,570,256         2,440,178   

Less accumulated depreciation and amortization

     1,479,359         1,433,865   
  

 

 

    

 

 

 

Net property, plant and equipment

     1,090,897         1,006,313   

Other assets and intangibles

     728,804         713,570   
  

 

 

    

 

 

 

Total assets

   $ 3,269,055       $ 3,068,081   
  

 

 

    

 

 

 

LIABILITIES AND EQUITY

     

Current portion of long-term debt

   $ 12,795       $ 8,983   

Other current liabilities

     389,599         355,194   
  

 

 

    

 

 

 

Total current liabilities

     402,394         364,177   
  

 

 

    

 

 

 

Long-term debt

     878,384         851,927   

Other noncurrent liabilities

     204,606         266,661   

Deferred income taxes

     113,048         109,570   

Albemarle Corporation shareholders’ equity

     1,587,571         1,416,074   

Noncontrolling interests

     83,052         59,672   
  

 

 

    

 

 

 

Total liabilities & equity

   $ 3,269,055       $ 3,068,081   
  

 

 

    

 

 

 

See accompanying notes to the condensed consolidated financial information.

 

6


Albemarle Corporation and Subsidiaries

Selected Consolidated Cash Flow Data

(In Thousands) (Unaudited)

 

     Nine Months Ended
September 30,
 
     2011     2010  

Cash and cash equivalents at beginning of year

   $ 529,650      $ 308,791   

Cash and cash equivalents at end of period

   $ 481,258      $ 424,673   

Sources of cash and cash equivalents:

    

Net income

     360,419        248,020   

Proceeds from borrowings

     132,859        58,710   

Proceeds from exercise of stock options

     1,103        4,679   

Uses of cash and cash equivalents:

    

Capital expenditures

     (127,111     (50,006

Repurchases of common stock

     (178,132     (14,945

Repayments of long-term debt

     (105,076     (109,346

Dividends paid to shareholders

     (43,098     (36,883

Pension and postretirement contributions

     (57,555     (27,139

Cash impact from deconsolidation of Stannica JV, net

     —          (13,074

Investments in equity and other corporate investments

     (10,868     (5

Non-cash items:

    

Depreciation and amortization

     71,926        71,486   

Restructuring and other charges (a)

     —          6,958   

Equity in net income of unconsolidated investments

     (37,118     (29,950

See accompanying notes to the condensed consolidated financial information.

 

7


Albemarle Corporation and Subsidiaries

Consolidated Summary of Segment Results

(In Thousands) (Unaudited)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011     2010  

Net sales:

        

Polymer Solutions

   $ 243,931      $ 231,847      $ 792,604      $ 683,789   

Catalysts

     299,531        214,785        827,339        658,438   

Fine Chemistry

     179,515        138,404        541,672        415,562   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net sales

   $ 722,977      $ 585,036      $ 2,161,615      $ 1,757,789   
  

 

 

   

 

 

   

 

 

   

 

 

 

Segment operating profit:

        

Polymer Solutions

   $ 55,219      $ 58,699      $ 203,900      $ 145,193   

Catalysts

     93,682        61,721        209,251        167,056   

Fine Chemistry

     34,793        17,799        111,387        50,251   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total segment operating profit

     183,694        138,219        524,538        362,500   
  

 

 

   

 

 

   

 

 

   

 

 

 

Equity in net income of unconsolidated investments:

        

Polymer Solutions

     1,357        2,040        6,496        6,859   

Catalysts

     8,170        7,166        30,796        23,173   

Fine Chemistry

     —          —          —          —     

Corporate & other

     (27     (27     (174     (82
  

 

 

   

 

 

   

 

 

   

 

 

 

Total equity in net income of unconsolidated investments

     9,500        9,179        37,118        29,950   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to noncontrolling interests:

        

Polymer Solutions

     (2,021     (2,235     (9,200     (4,749

Catalysts

     —          —          —          —     

Fine Chemistry

     (4,789     (1,291     (14,439     (4,443

Corporate & other

     (50     195        57        (80
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net income attributable to noncontrolling interests

     (6,860     (3,331     (23,582     (9,272
  

 

 

   

 

 

   

 

 

   

 

 

 

Segment income:

        

Polymer Solutions

     54,555        58,504        201,196        147,303   

Catalysts

     101,852        68,887        240,047        190,229   

Fine Chemistry

     30,004        16,508        96,948        45,808   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total segment income

     186,411        143,899        538,191        383,340   

Corporate & other

     (23,462     (17,488     (72,889     (52,242

Restructuring and other charges (a)

     —          —          —          (6,958

Interest and financing expenses

     (9,710     (6,139     (28,576     (18,059

Other income, net

     956        1,303        534        1,584   

Income tax expense

     (38,097     (27,886     (100,423     (68,917
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to Albemarle Corporation

   $ 116,098      $ 93,689      $ 336,837      $ 238,748   
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to the condensed consolidated financial information.

 

8


Notes to the Condensed Consolidated Financial Information

 

(a) The nine months ended September 30, 2010 included charges amounting to $7.0 million ($4.6 million after income taxes, or 5 cents per share) that related principally to reductions in force at our Bergheim, Germany site.

Additional Information

It should be noted that earnings, earnings per share and effective income tax rates which exclude special items, as well as presentations of segment operating profit, segment income, EBITDA, EBITDA excluding special items, EBITDA margin and EBITDA margin excluding special items are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These measures are presented here to provide additional useful measurements to review our operations, provide transparency to investors and enable period-to-period comparability of financial performance.

A description of other non-GAAP financial measures that we use to evaluate our operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, can be found in the Investors section of our website at www.albemarle.com, under “Non-GAAP Reconciliations” under “Financials.” Also, see attached for a supplemental reconciliation of our segment operating profit and segment income amounts to GAAP Operating profit and GAAP Net income attributable to Albemarle Corporation, respectively, as well as for a supplemental reconciliation of our GAAP Net income attributable to Albemarle Corporation to EBITDA and EBITDA excluding special items.

 

9


ALBEMARLE CORPORATION AND SUBSIDIARIES

Non-GAAP Reconciliation

(In Thousands)

(Unaudited)

Our segment information includes measures we refer to as “segment operating profit,” “segment income,” “EBITDA” and “EBITDA excluding special items,” which are financial measures that are not required by, or presented in accordance with, GAAP. The Company has reported segment operating profit, segment income, EBITDA and EBITDA excluding special items because management believes that these financial measures provide transparency to investors and enable period-to-period comparability of financial performance. Segment operating profit, segment income, EBITDA and EBITDA excluding special items should not be considered as alternatives to operating profit or net income attributable to Albemarle Corporation, as determined in accordance with GAAP.

See below for a reconciliation of segment operating profit and segment income, the non-GAAP financial measures, to operating profit and net income attributable to Albemarle Corporation, respectively, the most directly comparable financial measures calculated and reported in accordance with GAAP.

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011     2010  

Total segment operating profit

   $ 183,694      $ 138,219      $ 524,538      $ 362,500   

Corporate & other *

     (23,385     (17,656     (72,772     (52,080

Restructuring and other charges

     —          —          —          (6,958
  

 

 

   

 

 

   

 

 

   

 

 

 

GAAP Operating profit

   $ 160,309      $ 120,563      $ 451,766      $ 303,462   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total segment income

   $ 186,411      $ 143,899      $ 538,191      $ 383,340   

Corporate & other

     (23,462     (17,488     (72,889     (52,242

Restructuring and other charges

     —          —          —          (6,958

Interest and financing expenses

     (9,710     (6,139     (28,576     (18,059

Other income, net

     956        1,303        534        1,584   

Income tax expense

     (38,097     (27,886     (100,423     (68,917
  

 

 

   

 

 

   

 

 

   

 

 

 

GAAP Net income attributable to Albemarle Corporation

   $ 116,098      $ 93,689      $ 336,837      $ 238,748   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

* Excludes corporate equity income and noncontrolling interest adjustments of $(77) and $168 for the three-month periods ended September 30, 2011 and 2010, respectively, and $(117) and $(162) for the nine-month periods ended September 30, 2011 and 2010, respectively.

 

10


See below for a reconciliation of EBITDA and EBITDA excluding special items, the non-GAAP financial measures, from net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. EBITDA is defined as Net income attributable to Albemarle Corporation before interest and financing expenses, income taxes, depreciation and amortization. EBITDA excluding special items is defined as EBITDA before the special item as listed below.

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011     2010  

Net income attributable to Albemarle Corporation

   $ 116,098      $ 93,689      $ 336,837      $ 238,748   
  

 

 

   

 

 

   

 

 

   

 

 

 

Add:

        

Interest and financing expenses

     9,710        6,139        28,576        18,059   

Income tax expense

     38,097        27,886        100,423        68,917   

Depreciation and amortization

     24,616        23,075        71,926        71,486   
  

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     188,521        150,789        537,762        397,210   

Restructuring and other charges

     —          —          —          6,958   
  

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA excluding special item

   $ 188,521      $ 150,789      $ 537,762      $ 404,168   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net sales

   $ 722,977      $ 585,036      $ 2,161,615      $ 1,757,789   
  

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA Margin

     26.1     25.8     24.9     22.6
  

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA Margin excluding special item

     26.1     25.8     24.9     23.0
  

 

 

   

 

 

   

 

 

   

 

 

 

 

11